IL-23 receptor drugs for Psoriasis

4 tracked IL-23 receptor drugs in the Psoriasis race. The class explanation lives on the IL-23 receptor page; the full indication pipeline across every mechanism is on the Psoriasis page.

1 approved / phase 42 Phase 21 preclinical / unstaged

Head-to-head evidence: ABBV-859 vs icotrokinra · HS-20118 vs icotrokinra · HSK47388 vs icotrokinra

The roster

← all IL-23 receptor drugs